SEC Form D private-offering filing
AdvanCell, Inc.
A new SEC Form D private-offering notice from Cambridge, MA, a $315,000,000 filer-stated offering target in Biotech. The source filing is one click away.
Clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, with US headquarters in Cambridge, Massachusetts.
Filed 6 days agoFiled to raise $315,000,000First money in 2026-06-30Raised so far $218,333,294HQ (as filed) Cambridge, MASector Biotech ✓Stage (inferred) LateCall status Call-ready
Source linked the Form D on EDGAR↗Website verified advancell.com.au↗Named in the filing 11 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.